EagleClaw Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952K | Sell |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $837K | Hold |
|
|||||
|
2024
Q3 | $760K | Buy |
|
|||||
|
2024
Q2 | $599K | Hold |
|
|||||
|
2024
Q1 | $640K | Sell |
|
|||||
|
2023
Q4 | $747K | Hold |
|
|||||
|
2023
Q3 | $691K | Sell |
|
|||||
|
2023
Q2 | $753K | Sell |
|
|||||
|
2023
Q1 | $836K | Sell |
|
|||||
|
2022
Q4 | $942K | Hold |
|
|||||
|
2022
Q3 | $677K | Buy |
|
|||||
|
2022
Q2 | $666K | Buy |
|
|||||
|
2022
Q1 | $623K | Sell |
|
|||||
|
2021
Q4 | $1M | Sell |
|
|||||
|
2021
Q3 | $2.99M | Buy |
|
|||||
|
2021
Q2 | $2.92M | Buy |
|
|||||
|
2021
Q1 | $2.67M | Buy |
|
|||||
|
2020
Q4 | $2.27M | Sell |
|
|||||
|
2020
Q3 | $2.73M | Buy |
|
|||||
|
2020
Q2 | $3.31M | Sell |
|
|||||
|
2020
Q1 | $3.29M | Buy |
|
|||||
|
2019
Q4 | $2.84M | Buy |
|
|||||
|
2019
Q3 | $2.52M | Buy |
|
|||||
|
2019
Q2 | $2.22M | Buy |
|
|||||
|
2019
Q1 | $1.73M | Buy |
|
|||||
|
2018
Q4 | $1.65M | Sell |
|
|||||
|
2018
Q3 | $2.14M | Buy |
|
|||||
|
2018
Q2 | $1.65M | Sell |
|
|||||
|
2018
Q1 | $1.76M | Buy |
|
|||||
|
2017
Q4 | $1.61M | Buy |
|
|||||
|
2017
Q3 | $1.78M | Buy |
|
|||||
|
2017
Q2 | $1.33M | Sell |
|
|||||
|
2017
Q1 | $1.32M | Sell |
|
|||||
|
2016
Q4 | $1.41M | Sell |
|
|||||
|
2016
Q3 | $1.64M | Buy |
|
|||||
|
2016
Q2 | $1.66M | Buy |
|
|||||
|
2016
Q1 | $1.5M | Buy |
|
|||||
|
2015
Q4 | $1.26M | Buy |
|
|||||
|
2015
Q3 | $1.18M | Buy |
|
|||||
|
2015
Q2 | $1.21M | Buy |
|
|||||
|
2015
Q1 | $925K | Buy |
|
|||||
|
2014
Q4 | $850K | Buy |
|
|||||
|
2014
Q3 | $901K | Buy |
|
|||||
|
2014
Q2 | $686K | Buy |
|